VRIGLIB M TABLET
Generic Salt Composition: Glibenclamide 5mg + Metformin 500mg SR
Price: ₹15 MRP: ₹45.94
Save up to 67% compared to branded medicines.
Top Brand Substitutes & Equivalents
Glycomet-GP, Glibenclamide and Metformin Hydrochloride, Gluconorm-G, Semi-Daonil, Metformin Glibenclamide SR, Glynase-MF, Diabetrol, Glucored, Glibomet, Euglucon-M, Met-G, Gliben-M, Glucovance, Glibenclamide-Metformin SR, Metformin-Glibenclamide, Glibenclamide 5mg Metformin 500mg, Glyciphage-G, Glibenclamide-Metformin, Glycomet 500 SR, Glycomet 850, Glycomet 1000 SR, Cetapin 500, Cetapin 1000, Glucophage 500, Glucophage XR 1000, Obimet 500, Obimet 1000, Formin 500, Exermet 500, Metfor 500
Product Overview & Uses
VRIGLIB M TABLET is a potent oral antihyperglycemic agent designed for the management of Type 2 Diabetes Mellitus. As a product within the Uncategory classification, it utilizes a synergistic approach by combining Glibenclamide, which enhances pancreatic insulin release, and Metformin, which reduces hepatic glucose production and increases insulin sensitivity in muscle tissues. This dual-action mechanism makes VRIGLIB M TABLET an effective choice for patients who have not achieved adequate glycemic control through diet and exercise alone. By addressing both insulin deficiency and insulin resistance, this medication helps prevent long-term complications associated with chronic hyperglycemia, such as neuropathy, retinopathy, and cardiovascular issues. Patients using VRIGLIB M TABLET should be monitored regularly for blood glucose levels and potential side effects like hypoglycemia.